SCHEMBL7232127

SCHEMBL7232127

O=C(N[C@@H]1C[C@H]2CC[C@@H]1N2)c1ccc(-c2ccccc2Oc2ccccc2)o1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.48
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
MAPT P10636 3/20 0.40
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232158 0.90 ALDH1A1 (0.50) SLC9A1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL7222966 0.86 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL7225022 0.86 NPC1 (0.42) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL7234830 0.84 RAB9A (0.42) RAB9ANPC1MAPTHTR3EHTR3B
SCHEMBL7232857 0.84 RAB9A (0.40) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL7224300 0.84 RAB9A (0.40) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL7225840 0.83 RAB9A (0.41) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL7231145 0.83 SLC9A1 (0.44) SLC9A1RAB9ANPC1HTR3EHTR3B
SCHEMBL7226764 0.83 RAB9A (0.53) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL7072612 0.83 RAB9A (0.49) SLC9A1ALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed